We are a preclinical stage company developing iPSC-derived T cells for treatment of cancer and immune disorders.
Investors 1
| Date | Name | Website |
| 01.03.2022 | MBC BioLab... | mbcbiolabs... |
| Date | Name | Website |
| 01.03.2022 | MBC BioLab... | mbcbiolabs... |